We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
Triad Pharmaceuticals Adopts new Name of Arisaph Pharmaceuticals
News

Triad Pharmaceuticals Adopts new Name of Arisaph Pharmaceuticals

New name establishes unique identity and reflects company mission.
OSI Pharmaceuticals Completes its Acquisition of Eyetech Pharmaceuticals
News

OSI Pharmaceuticals Completes its Acquisition of Eyetech Pharmaceuticals

The transaction leverages the Company's core expertise in drug discovery and development.
Xenome Strengthens Management Team and Launches US Presence
News

Xenome Strengthens Management Team and Launches US Presence

David Slack, Richard Lewis, Kathryn Radford and Katherine Nielsen have been appointed to strengthened the management team.
Funding Round For Cambridge Biotech Company Completed
News

Funding Round For Cambridge Biotech Company Completed

The funds will be invested in further research and development while expanding Activotec’s current business.
PolyMedix Appoints Vice President of Drug Development
News

PolyMedix Appoints Vice President of Drug Development

Timothy Henkel, Appointed Vice President of Drug Development and Chief Medical Officer.
deCODE Describes Genetic Risk Factor for Heart Attack
News

deCODE Describes Genetic Risk Factor for Heart Attack

The study builds upon deCODE's previously published work linking variants of the gene.
Velcura Therapeutics and GeneGo Enter Multi Year Agreement
News

Velcura Therapeutics and GeneGo Enter Multi Year Agreement

All Velcura employees will have access to the MetaCore database.
BioTrove and Sitris Expand HTS Relationship
News

BioTrove and Sitris Expand HTS Relationship

BioTrove will use RapidFire™ Lead Discovery service for assay development and high throughput screening of Sirtris targets.
Metabolon Appoints Chief Scientific Officer
News

Metabolon Appoints Chief Scientific Officer

Dr. Michael Milburn has been appointed as Chief Scientific Officer.
Affibody and NIH to Develop Molecular In Vivo Imaging Agents
News

Affibody and NIH to Develop Molecular In Vivo Imaging Agents

Affibody will design and develop engineered Affibody® molecules specific for a receptor protein, HER2.
Advertisement